임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

14건 표시

2상모집 중· Primary Brain Tumor
Belvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors
협력: 한미약품
상세 →NCT07688356
2상모집 중· Type 2 Diabetes Mellitus
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
리드: 한미약품
상세 →NCT07527650
3상모집 중· Type 2 Diabetes
A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin
리드: 한미약품
상세 →NCT07379333
해당없음모집 중· Dyslipidemia Associated With Type II Diabetes Mellitus
Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)
협력: 한미약품, 유한양행
상세 →NCT07359105
2상모집 중· Advanced or Metastatic Melanoma
Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
리드: 한미약품
상세 →NCT07449754
1상모집 중· Obesity
A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants
리드: 한미약품
상세 →NCT07219589
1/2상모집 중· Fabry Disesase
A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Disease
리드: GC녹십자 · 협력: 한미약품
상세 →NCT06858397
4상모집 중· Coronary Artery Disease
Comparison of Moderate-Intensity Statin Plus Ezetimibe vs. High-Intensity Statin for Coronary Plaque Stabilization
협력: 한미약품, 유한양행
상세 →NCT06767345
1상모집 중· Advanced or Metastatic Solid Tumors
Dose Escalation and Expansion Study of HM16390 Alone or With Pembrolizumab in Advanced or Metastatic Solid Tumors
리드: 한미약품 · 협력: 머크(MSD)
상세 →NCT06724016
해당없음모집 중· Ischemic Stroke
Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke
협력: 한미약품
상세 →NCT06649240
1상모집 중· Advanced or Metastatic Solid Tumors
Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors
리드: 한미약품 · 협력: 머크(MSD)
상세 →NCT06234397
4상모집 중· Coronary Artery Disease
Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION)
협력: 대웅제약, 한미약품, 유한양행
상세 →NCT05845489
1상모집 중· Advanced or Metastatic Solid Tumors
Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors
리드: 한미약품
상세 →NCT05598151
2상모집 중· Short Bowel Syndrome
Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
리드: 한미약품
상세 →NCT04775706

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.